发明名称 Himbacine analogues as thrombin receptor antagonists.
摘要 Heterocyclic-substituted tricyclics of the formula or a pharmaceutically acceptable salts thereof, wherein: n<SUB>1 </SUB>and n<SUB>2 </SUB>are independently 0-2; Het is an optionally substituted mono-, bi- or tricyclic heteroaromatic group; B is alkyl or optionally substituted alkenyl; R<SUP>22 </SUP>is -COR<SUP>23 </SUP>or a carboxy, sulfinyl, sulfonyl, sulfonamide or amino acid derivative; R<SUP>23 </SUP>is haloalkyl; alkenyl; haloalkenyl; alkynyl; optionally substituted cycloalkyl; cycloalkyl-alkyl; aryl; arylalkyl; heteroaryl; heterocycloalkyl; or -COOH and/or -SO<SUB>3</SUB>H substituted alkyl; R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>9</SUP>, R<SUP>10 </SUP>and R<SUP>11 </SUP>are as defined in the specification; are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds.
申请公布号 ZA200402849(B) 申请公布日期 2005.01.14
申请号 ZA20040002849 申请日期 2004.04.15
申请人 SCHERING CORPORATION 发明人 SAMUEL CHACKALAMANNIL;MARTIN C. CLASBY;MARIAPPAN V. CHELLIAH;YAN XIA
分类号 C07D491/048;A61K31/444;A61P7/02;A61P9/00;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P13/12;A61P19/02;A61P29/00;A61P35/00;A61P43/00;C07D491/04;C07D493/04;C07D495/04 主分类号 C07D491/048
代理机构 代理人
主权项
地址